• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?

作者信息

Huo Teh-Ia, Liao Jia-I, Ho Shu-Yein

机构信息

Division of Basic Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

出版信息

J Hepatol. 2022 Apr;76(4):987-988. doi: 10.1016/j.jhep.2021.11.007. Epub 2021 Nov 13.

DOI:10.1016/j.jhep.2021.11.007
PMID:34780876
Abstract
摘要

相似文献

1
Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?接受免疫治疗的肝细胞癌患者的预后预测：我们做到了吗？
J Hepatol. 2022 Apr;76(4):987-988. doi: 10.1016/j.jhep.2021.11.007. Epub 2021 Nov 13.
2
Reply to: "Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?".回复：“肝细胞癌患者接受免疫治疗的预后预测：我们做到了吗？”
J Hepatol. 2022 Apr;76(4):988-989. doi: 10.1016/j.jhep.2021.12.025. Epub 2021 Dec 31.
3
Hepatocellular carcinoma in the era of immunotherapy.免疫治疗时代的肝细胞癌
Curr Probl Cancer. 2018 Jan-Feb;42(1):40-48. doi: 10.1016/j.currproblcancer.2017.10.007. Epub 2017 Nov 15.
4
Cancer-Testis Gene Expression in Hepatocellular Carcinoma: Identification of Prognostic Markers and Potential Targets for Immunotherapy.肝癌中癌-睾丸基因的表达：预后标志物的鉴定和免疫治疗的潜在靶点。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820944274. doi: 10.1177/1533033820944274.
5
The CRAFITY score: A new guidepost for prognosis prediction in patients with hepatocellular carcinoma undergoing immunotherapy.CRAFITY评分：接受免疫治疗的肝细胞癌患者预后预测的新指标。
J Hepatol. 2022 May;76(5):1232-1233. doi: 10.1016/j.jhep.2021.12.033. Epub 2022 Jan 19.
6
Reply to: "The CRAFITY score: A new guidepost for prognosis prediction in patients with hepatocellular carcinoma undergoing immunotherapy".回复：“CRAFITY评分：接受免疫治疗的肝细胞癌患者预后预测的新指南”。
J Hepatol. 2022 May;76(5):1233-1234. doi: 10.1016/j.jhep.2022.02.002. Epub 2022 Feb 14.
7
Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation.肿瘤大小仍是预测肝移植后肝细胞癌复发的关键因素。
Ann Surg Oncol. 2011 May;18(5):1217-8. doi: 10.1245/s10434-011-1589-3.
8
Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma.免疫疗法作为肝细胞癌肝移植的降期工具
Am J Gastroenterol. 2021 Dec 1;116(12):2478-2480. doi: 10.14309/ajg.0000000000001391.
9
TATI modality: A new perspective on the treatment of advanced hepatocellular carcinoma.经动脉化疗栓塞术（TATI）治疗方式：晚期肝细胞癌治疗的新视角。
J Cancer Res Ther. 2020 Sep;16(5):957-959. doi: 10.4103/jcrt.JCRT_850_20.
10
Immunotherapy for hepatocellular carcinoma.肝细胞癌的免疫疗法
Drug Discov Ther. 2015 Oct;9(5):363-71. doi: 10.5582/ddt.2015.01054.

引用本文的文献

1
High expression of small nucleolar host gene RNA may predict poor prognosis of Hepatocellular carcinoma, based on systematic reviews and meta-analyses.基于系统评价和荟萃分析，小核仁宿主基因 RNA 的高表达可能预示着肝细胞癌的预后不良。
BMC Cancer. 2024 Sep 5;24(1):1110. doi: 10.1186/s12885-024-12590-2.